COVID-19 drug resistance

被引：0
|
作者：
Devi, Sharmila
机构：
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：538 / 538
页数：1
相关论文
共 50 条
  • [41] Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
    Angel Martinez, Miguel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [42] Drug-utilisation profiles and COVID-19
    Orlando, Valentina
    Coscioni, Enrico
    Guarino, Ilaria
    Mucherino, Sara
    Perrella, Alessandro
    Trama, Ugo
    Limongelli, Giuseppe
    Menditto, Enrica
    SCIENTIFIC REPORTS, 2021, 11 (01) : 8913
  • [43] COVID-19 and Drug Shortages: A Call to Action
    Shuman, Andrew G.
    Fox, Erin R.
    Unguru, Yoram
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (08): : 945 - 947
  • [44] Teicoplanin: an alternative drug for the treatment of COVID-19?
    Baron, Sophie Alexandra
    Devaux, Christian
    Colson, Philippe
    Raoult, Didier
    Rolain, Jean-Marc
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [45] Explosive drug information in the time of COVID-19
    Schulz, Martin
    Schumacher, Pia M.
    Schneider, Juliana
    Said, Andre
    Laufs, Ulrich
    CANADIAN PHARMACISTS JOURNAL, 2021, 154 (04) : 232 - 233
  • [46] Drug Shortages Amid the COVID-19 Pandemic
    Bookwalter, Christina M.
    US PHARMACIST, 2021, 46 (02) : 25 - 28
  • [47] Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
    Devaux, Christian A.
    Melenotte, Clea
    Piercecchi-Marti, Marie-Dominique
    Delteil, Clemence
    Raoult, Didier
    FRONTIERS IN MEDICINE, 2021, 8
  • [48] Editorial: Drug Repurposing for COVID-19 Therapy
    Maldonado, Rafael
    Drago, Filippo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] COVID-19 drug studies get boost
    Brainard, Jeffrey
    SCIENCE, 2021, 372 (6549) : 1372 - 1372
  • [50] A review on drug repurposing applicable to COVID-19
    Dotolo, Serena
    Marabotti, Anna
    Facchiano, Angelo
    Tagliaferri, Roberto
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 726 - 741
12345